A 56-year-old man presented with mild anemia, a slight increase in platelets (leukocyte count, 4920/µL; hemoglobin, 11.5 g/dL; platelet count, 375 × 103/μL), and mild splenomegaly. A postmediastinal mass was noted on computed tomography (arrow; panel A). The resected mass was ∼2.5 cm in diameter (panel B). Histologically, the lesion was trilineage hematopoietic tissue and diagnosed as extramedullary hematopoiesis (EMH) with erythroid predominance (panels C and E; hematoxylin and eosin stain [C], CD71 [E]; original magnification ×200). Hypolobular granulocytes and megaloblastic change in erythroid cells were found on touch specimen (panel D; May-Giemsa stain, original magnification ×600). Dysplastic megakaryocytes (panel F; CD61, original magnification ×400), aggregation of fetal hemoglobin–positive cells (panel G, arrows; original magnification ×200), and a few scattered p53+ cells were also observed. CD34+ blasts did not increase. Because peripheral blood abnormalities remained, bone marrow aspiration was performed. Histologically, the findings were similar to those of EMH; however, Berlin blue staining revealed many sideroblasts in the clot, which were confirmed to be ring sideroblasts on the smear specimen (58% of erythroid series, panels H and I, arrows; May-Giemsa stain [H], Berlin blue stain [I]; original magnification, ×1000). Berlin blue staining for EMH tissue was performed afterward, and many sideroblasts were detected. (panel J, original magnification, ×1000). BCR-ABL, JAK2, MPL, and CALR mutation and del(5q) tests were negative genetically (SF3B1 mutation testing not performed).
The final diagnosis was myelodysplastic syndrome with ring sideroblasts.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal